https://scholars.lib.ntu.edu.tw/handle/123456789/627199
標題: | Quality of life assessment of cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial | 作者: | Freemantle, Nick Mollon, Patrick Meyer, Tim ANN-LII CHENG El-Khoueiry, Anthony B Kelley, Robin K Baron, Ari D Benzaghou, Fawzi Mangeshkar, Milan Abou-Alfa, Ghassan K |
關鍵字: | Cabozantinib; Carcinoma; Hepatocellular; Liver neoplasms; Patient Reported Outcome Measures; Patient health questionnaire; Quality-adjusted life years; Visual analog scale | 公開日期: | 六月-2022 | 出版社: | ELSEVIER SCI LTD | 卷: | 168 | 起(迄)頁: | 91 | 來源出版物: | European journal of cancer (Oxford, England : 1990) | 摘要: | The CELESTIAL trial (NCT01908426) demonstrated overall survival benefit for cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (aHCC) who had received prior sorafenib treatment. This analysis of CELESTIAL compared the impact of cabozantinib versus placebo on health-related quality of life (HRQoL). |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/627199 | ISSN: | 0959-8049 | DOI: | 10.1016/j.ejca.2022.03.021 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。